Q4FY21 Company Update - Hester Biosciences - ICICI Direct

Q4 revenues grew 47.1% to Rs. 64.2 crore due to 74.4% growth in poultry segment to Rs. 52.7 crore as bird-flu incidences led to higher usage of preventive and curative poultry vaccines and health products. However, animal healthcare segment de-grew 11.6% YoY to Rs. 11.5 crore. EBITDA margins, not comparable YoY due to pandemic impacted base, came in at 30.8% (16.5% in Q4FY20). EBITDA came in at Rs. 19.8 crore, ~2.8x YoY. Adjusting for exceptional loss on Patan farm disposal, PAT came in at Rs. 13 crore vs. Rs. 2.7 crore in Q4FY20.

For details, click on the link below: Link to the report

Shares of HESTER BIOSCIENCES LTD. was last trading in BSE at Rs.2717.15 as compared to the previous close of Rs. 2758.65. The total number of shares traded during the day was 14600 in over 2193 trades.

The stock hit an intraday high of Rs. 2876.85 and intraday low of 2675. The net turnover during the day was Rs. 40551991.

Source : Equity Bulls

Keywords